Moderna, Inc. (MRNA) — 10-Q Filings

10-Q Filings (6)

• Moderna's Q3 Loss Widens Amidst Revenue Dip, R&D Spend Cuts — Nov 6, 2025 Risk: high
  Moderna, Inc. (MRNA) reported a significant net loss of $200 million for the three months ended September 30, 2025, a substantial decline from a net income of $
• Moderna's Sales Plummet 62% Amid Post-Pandemic Vaccine Shift — Aug 1, 2025 Risk: high
  Moderna, Inc. reported product sales of $1.1 billion for the three months ended June 30, 2025, a significant decrease from $2.9 billion in the same period of 20
• Moderna Files Q1 2025 10-Q — May 1, 2025 Risk: medium
  Moderna, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations for the first quarter of 202
• Moderna Files Q3 2024 10-Q with Financial Updates — Nov 7, 2024 Risk: medium
  Moderna, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its development progra
• Moderna Files Q2 2024 10-Q — Aug 1, 2024 Risk: medium
  Moderna, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and business operations for the second quarter of 202
• Moderna, Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: medium
  Moderna, Inc. (MRNA) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Moderna, Inc. reported financial results for the first quarter of 2024. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX